Major depressive disorder (MDD) is one of the most common medical conditions in the world — affecting an estimated 21 million adults in the United States each year, and a leading cause of disability globally. It is also one of the most misunderstood, frequently dismissed as weakness or sadness rather than recognized as the genuine neurobiological condition it is. Understanding MDD clearly — its diagnostic criteria, its causes, its severity spectrum, and the full range of treatments — is the foundation for getting appropriate help.
This article covers the DSM-5 criteria for MDD, what science has revealed about its causes, severity levels, the treatment spectrum, and when residential care is the right step. If depression is affecting your life or someone you love, this is the accurate clinical picture.
DSM-5 CRITERIA FOR MDD
Major depressive disorder is defined in the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) by specific criteria that distinguish clinical depression from ordinary sadness or grief. The diagnosis requires:
- At least five of the following symptoms, present during the same two-week period, representing a change from previous functioning:
- Depressed mood most of the day, nearly every day (can be observed by others; in children and adolescents, may be irritable mood)
- Markedly diminished interest or pleasure in almost all activities (anhedonia)
- Significant weight loss or gain, or decrease or increase in appetite
- Insomnia or hypersomnia (sleeping too much or too little)
- Psychomotor agitation or retardation observable by others
- Fatigue or loss of energy
- Feelings of worthlessness or excessive or inappropriate guilt
- Diminished ability to think, concentrate, or make decisions
- Recurrent thoughts of death, suicidal ideation, or a suicide attempt
- At least one of the first two symptoms (depressed mood OR anhedonia) must be present.
- The symptoms cause clinically significant distress or impairment in functioning.
- The episode is not attributable to a substance or medical condition.
- The episode is not better explained by another psychiatric disorder.
This clinical specificity matters for two reasons: it establishes that major depression is a definable, diagnosable medical condition (not simply sadness), and it ensures that treatment is directed at a real clinical entity rather than a vague feeling.
CAUSES: BIOLOGICAL, PSYCHOLOGICAL, SOCIAL
Depression doesn’t have a single cause. The best-supported understanding of MDD is a biopsychosocial model: it emerges from the interaction of biological vulnerabilities, psychological patterns, and social and environmental circumstances. Understanding these helps explain why different people develop depression under different circumstances and why no single treatment is universally effective.
Biological factors:
- Neurochemistry. Imbalances in neurotransmitters — particularly serotonin, norepinephrine, and dopamine — are well-associated with depression, and this is the basis for antidepressant medication.
- Neuroscience beyond chemistry. Brain imaging reveals structural and functional differences in depressed brains, including in areas regulating emotion, stress, reward, and executive function.
- Genetics. Depression runs in families, with a significant heritable component — though genes predispose rather than determine.
- HPA axis and stress. The hypothalamic-pituitary-adrenal axis, which governs the stress response, is often dysregulated in depression. Chronic stress literally alters brain structure and function.
- Medical conditions. Thyroid disorders, chronic pain, sleep disorders, and other medical conditions can cause or worsen depression.
Psychological factors:
- Cognitive patterns. Depressive thinking — persistent negative views of oneself, the world, and the future (Aaron Beck’s “cognitive triad”) — maintains and deepens depression.
- Learned helplessness. The belief, formed through experience, that one cannot affect one’s circumstances undermines motivation and action.
- Rumination. The tendency to repetitively dwell on negative thoughts and feelings amplifies depression.
- Trauma and adversity. Early life adversity and trauma are among the strongest predictors of later depression, altering how the brain develops and responds to stress.
Social factors:
- Interpersonal difficulties. Conflict, loss, isolation, and poor social support are strongly associated with depression onset and maintenance.
- Life circumstances. Poverty, unemployment, chronic stress, caregiver burden, and other life circumstances create sustained strain that can precipitate depression in vulnerable individuals.
- Social isolation. One of the most consistently powerful factors maintaining depression is social isolation and withdrawal — themselves symptoms that also perpetuate the condition.
The biopsychosocial model explains why effective treatment addresses all three domains: medication for biology, therapy for psychology, and support and environmental interventions for the social dimension.
SEVERITY LEVELS
Not all depression presents with the same intensity, and treatment appropriately varies by severity.
Mild MDD. Symptoms meet diagnostic criteria but are on the lower end of intensity, with less severe functional impairment. Often responds well to psychotherapy alone (particularly CBT), with medication as an option.
Moderate MDD. Symptoms are more prominent and functional impairment more significant. Usually benefits from both medication and therapy; outpatient treatment is often sufficient.
Severe MDD. Significant symptoms causing marked functional impairment. May include psychotic features (in severe cases) or prominent suicidal ideation. Medication plus intensive therapy is standard; may require higher levels of care including residential treatment.
Treatment-resistant MDD. Depression that has not responded adequately to multiple treatment attempts. Requires reassessment, medication optimization, higher-intensity care, and potentially advanced treatment options.
Understanding severity matters because stepped-care — matching treatment intensity to clinical need — produces better outcomes than applying the same level of care to all presentations.
TREATMENT SPECTRUM
MDD is treated across a spectrum of evidence-based interventions, matched to severity and individual circumstances.
Psychotherapy:
- Cognitive behavioral therapy (CBT) is the most extensively evidence-supported therapy for depression, working by identifying and changing the negative thought patterns and behavioral avoidance that maintain the condition.
- Behavioral activation (BA), often considered a component of CBT, directly addresses the withdrawal and inactivity cycle.
- Interpersonal therapy (IPT) focuses on the interpersonal context of depression.
- Other modalities including DBT and psychodynamic approaches contribute in appropriate clinical contexts.
Medication:
- Antidepressants (SSRIs, SNRIs, and others) are the first-line pharmacological treatment. They work by modulating neurotransmitter systems.
- Effectiveness varies by individual; finding the right medication often requires trying more than one.
- Combination with therapy is consistently superior to either alone.
Combination (medication + therapy):
Research consistently shows that combining antidepressants with psychotherapy produces better outcomes than either alone for moderate to severe MDD. This is the standard of care for significant presentations.
Residential treatment:
For severe, treatment-resistant, or acutely impaired presentations, residential care provides the intensity, structure, and supervised medication management that outpatient cannot.
Advanced options:
Ketamine/esketamine, TMS, and ECT for refractory cases, as described in the treatment-resistant depression article. All advanced treatment decisions belong to qualified medical professionals.
WHEN RESIDENTIAL CARE IS RIGHT
Residential care for MDD is appropriate when outpatient treatment has been insufficient or is clinically inappropriate for the severity of the presentation. Indicators include severe functional impairment, treatment resistance, safety concerns, co-occurring substance use, need for supervised medication optimization, or a recovery-hostile home environment.
Oceánica’s residential program in Mazatlán, Mexico, provides 45 days of treatment — comprehensive psychiatric assessment, supervised medication management, twice-weekly individual therapy, five-times-weekly group therapy, behavioral activation, and structured aftercare planning — with a fully English-speaking CARF-accredited clinical team. Cost approximately $12,500–$13,500 USD.
FREQUENTLY ASKED QUESTIONS
What are the diagnostic criteria for major depressive disorder?
The DSM-5 requires at least five of nine specific symptoms present for at least two weeks, including depressed mood or anhedonia, causing significant distress or impairment and not better explained by another condition. A qualified clinician makes the diagnosis.
Is depression caused by a chemical imbalance?
The “chemical imbalance” explanation is simplified. Neurotransmitter dysregulation is real and relevant, but depression also involves neural circuit changes, HPA-axis dysfunction, genetic factors, and psychological and social factors. The biopsychosocial model captures the full picture better than any single-cause explanation.
Can major depression be treated without medication?
For mild to moderate MDD, psychotherapy alone — particularly CBT — can be effective. For moderate to severe presentations, the combination of medication and therapy consistently produces better outcomes than either alone. All treatment decisions are made with a qualified clinician based on individual circumstances.
When should someone consider residential treatment for depression?
When depression is severe, treatment-resistant, causing significant functional impairment, complicated by safety concerns or co-occurring conditions, or when outpatient treatment has not produced adequate results.
Recommended Reading
- Depression Treatment in Mexico: Residential Care That Works
- Treatment-Resistant Depression: When Standard Care Fails
- Mood Disorder Treatment in Mexico: 28-Day Intensive Program
- Services and Programs at Oceánica
EXTERNAL REFERENCE LINKS
Oceánica is a CARF-accredited residential treatment center in Mazatlán, Mexico, providing intensive treatment for major depressive disorder. This article is informational and not medical advice. If you are experiencing thoughts of self-harm, seek emergency care immediately. Call (213) 527-3377 or visit oceanica-usa.com.
